Requip - News Articles

PharmaLive: Teva Introduces Ropinirole Hydrochloride Tablets, 5 mg: May 20, 2008
PharmaLive.com (press release), PA -
This product is AB rated and bioequivalent to Requip(R)* Tablets. Additional information on this product is provided in the attached files. Enclosed are a press release and photograph of this new product for use in your journals. We believe this ...
Northern News - Ontario, CA: May 21, 2008
Northern Daily News, Canada -
I take one Requip tablet before I go to bed. Over a period of several months, I've noticed that my long-term memory is failing. Is it possible that this is a side effect of Requip? If so, can you suggest another treatment for RLS that is effective but less ...
Generic Firms Get FDA Nod for Requip: May 13, 2008
FDA news (subscription), VA -
The FDA has approved four generic versions of Requip, GlaxoSmithKline’s (GSK) restless leg treatment. Mylan, Par Pharmaceutical, Teva Pharmaceuticals and Roxane received approval of the drug, according to the FDA website. Requip (ropinirole HCl) ...
FDA OKs Generic Requip: May 14, 2008
WebMD -
By Miranda Hitti May 14, 2008 -- The FDA has approved generic versions of the drug Requip made by four companies. Generic ropinirole hydrochloride will be made by Teva Pharmaceuticals USA, Roxane Laboratories, Mylan Pharmaceuticals, and Par Pharmaceutical. Requip, ...
GSK Launches ReQuip XL(R) (ropinirole Prolonged-release Tablets) A New Once Daily Formulation For The Treatment Of Parkinson's Disease: May 19, 2008
Medical News Today (press release), UK -
ReQuip XL® (ropinirole prolonged-release tablets) is the UK's first and only once-daily non-ergot oral dopamine agonist available for the treatment of PD1, providing continuous delivery of ropinirole from a single daily dose2. Ropinirole prolonged-release is approved for the ...
FDA approves first generic drugs for restless leg syndrome: May 9, 2008
BusinessWeek -
The Food and Drug Administration said Friday it granted four companies approval to market the first generic versions of GlaxoSmithKline's drug for restless ...
News - FDA Approves Generic Ropinirole Hydrochloride for Treatment of Restless Legs Syndrome: May 9, 2008
DG News -
ROCKVILLE, Md. -- May 9, 2008 -- The US Food and Drug Administration (FDA) has approved the generic ropinirole hydrochloride (Requip) tablets for the treatment of moderate to severe restless legs syndrome. Ropinirole hydrochloride tablets have been approved ...
FDA approves generic Requip for restless legs syndrome - Forbes.com: May 9, 2008
Forbes, NY -
SAN FRANCISCO (Thomson Financial) - The Food and Drug Administration said Friday it has approved the first generic version of GlaxoSmithKline's Requip ...
FDA approves first generic drug for restless leg syndrome _English_Xinhua: May 9, 2008
Xinhua, China -
WASHINGTON, May 8 (Xinhua) -- The US Food and Drug Administration approved on Friday the first generic versions of Requip (ropinirole hydrochloride) tablets for the treatment of moderate to severe Restless Legs Syndrome.(Xinhua/Reuters ...
Pharma and Device Blog Watch: Jun 6, 2007
FDA news (subscription), VA -
indeed entertaining, much more so than that specially designed chair in the ReQuip DTC TV commercials seen in the US Could the video be adapted to DTC? It would have to be edited so that the product can be mentioned along with the benefits and ...

Northwest Herald - Local News and Video for McHenry County, Illinois - Dr. Gott: Reader takes too many meds: May 23, 2007
Northwest Herald, IL -
effective option for restless legs syndrome, a puzzling ailment for which there is now a prescription medication, Requip, which is safer than OxyContin. Second, your “bulging discs” should be addressed. If the discs are out of position and pressing on spinal nerves, you ...
The Spokesman-Review.com: May 24, 2007
The Spokesman Review, WA -
an effective option for restless legs syndrome, a puzzling ailment for which there is now a prescription medication, Requip, that shows great promise. ...
Requip exhibit new extended range of crusher wear parts at Hillhead 2007 - Hub-4: May 24, 2007
Hub 4 (press release), UK -
Requip Supplies will be promoting their extended range of spare and wear parts for impact, jaw and cone crushers to suit Hazemag, Hartl, Extec, Kleeman, Tesab, Rubblemaster, Nordberg, Pegson, Parker and Metso machines. The company holds comprehensive and extensive stocks including a wide range ...
UPDATE 1-XenoPort, Glaxo restless legs drug works in trial | Breaking City News | Reuters.co.uk: Apr 25, 2007
Reuters.uk, UK -
said in a recent note that XP13512 plus a new form of its existing drug Requip could double Glaxo's current RLS revenues in the key US market. ...
XenoPort reports positive results from Restless Leg Syndrome trial - Forbes.com: Apr 25, 2007
Forbes, NY -
Glaxo has been building a franchise around the largely untreated illness with its Requip pill, and is expected to launch an extended release version later this year. Sales of Requip, which is also sold as a treatment for the symptoms of Parkinson's disease, posted ...
Patch for early Parkinson's symptoms: May 9, 2007
WHBF, IL -
Presidential Campaign News from AP. WASHINGTON Patients with early Parkinson's disease have a new treatment option -- and it comes in the form of a patch. The once-daily Neuro patch is a first in American medical treatment for symptoms of the disease. It contains a drug ...
Therapeutics Daily: May 9, 2007
Therapeutics Daily (subscription) (press release), PA -
AP WorldStream - May. 09, 2007. WASHINGTON_The treatment options for patients with early Parkinson's expanded Wednesday with the approval of a new drug in patch form _ a first for medicines to treat symptoms of the disease. The once-daily ...
KVIA.com – El Paso, Las Cruces - Weather, News, Sports - Patch for early Parkinson's symptoms: May 9, 2007
KVIA, TX -
WASHINGTON Patients with early Parkinson's disease have a new treatment option -- and it comes in the form of a patch. The once-daily Neuro patch is a first in American medical treatment for symptoms of the disease. It contains a drug called rotigotine, which federal regulators say ...
SCHWARZ PHARMA: May 9, 2007
Ad-Hoc-News (Pressemitteilung), Germany -
transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. SCHWARZ PHARMA announced today that the U.S. Food and Drug Administration(FDA) has approved Neupro(TM) (Rotigotine Transdermal System) for thetreatment of the signs and ...
Health 24 - News, Research: May 10, 2007
Health24.com, South Africa -
In what's being described as the "most comprehensive drug safety overhaul in more than a decade," the US Senate voted overwhelmingly Wednesday to give the US Food and Drug Administration sweeping new powers to protect consumers from dangerous medicines. ...